AbCellera Biologics Inc (FRA:8QQ)
€ 2.3 0.009 (0.36%) Market Cap: 738.84 Mil Enterprise Value: 232.08 Mil PE Ratio: 0 PB Ratio: 0.79 GF Score: 71/100

Q4 2020 Abcellera Biologics Inc Earnings Call Transcript

Mar 29, 2021 / 09:00PM GMT
Operator

Good day, and thank you for standing by. Welcome to the AbCellera 2020 Business Update Conference call. (Operator Instructions)

I would now like to hand the conference over to Tryn Stimart. Thank you. Please go ahead.

Tryn T. Stimart
AbCellera Biologics Inc. - Chief Legal Officer & Corporate Secretary

Good afternoon, and welcome to AbCellera's first earnings conference call and our 2020 annual business update. We are pleased to have you with us today where we will discuss the results announced in our press release issued after the market closed today, which you can find on our Investor Relations website.

With me on the call today are Dr. Carl Hansen, AbCellera's President and Chief Executive Officer; and Andrew Booth, AbCellera's Chief Financial Officer. The webcast portion of this call contains a slide presentation that we will refer to during the call. Those of you following along on the phone, who wish to access the slide portion of this presentation, may do so on the Investor Relations section of our website. For those of you, who

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot